Aripiprazole treatment in the adolescent patients with inhalants use disorders and conduct disorder: A retrospective case analysis

Yeni Symposium

Volumn 48, Issue 3, 2010, Pages 229-233

  Erdogan, Ayten ^a   Yurteri, Nihal ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Adolescents; Aripiprazole; Conduct disorder; Inhalants

Indexed keywords

ARIPIPRAZOLE; CENTRAL STIMULANT AGENT; DOPAMINE 2 RECEPTOR; METHYLPHENIDATE; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENCE; ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONDUCT DISORDER; DEPRESSION; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; DRUG MECHANISM; HUMAN; INHALANT ABUSE; MALE; OPIATE ADDICTION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TOBACCO DEPENDENCE;

EID: 77955447035     PISSN: 13008773     EISSN: 13044591     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. American Psychiatric Association, (1994) Diagnostic and Statistical Manual of Psychiatric Disorders. Washington, DC.
2. Anderson CE, Loomis GA (2003) Recognition and Prevention of Inhalant Abuse. Am Fam Physician; 68: 869-874.
3. Anton RF, Kranzler H, Breder C, Marcus RN, Carson WH, Han J (2008) A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. J Clin Psychopharmacol; 28:5-12.
4. Beresford TP, Clapp L, Martin B, Wiberg JL, Alfers J, Beresford HF (2005) Aripiprazole in schizophrenia with cocaine dependence: A pilot study. J Clin Psychopharmacol; 25: 363-366. (Pubitemid 41060257)
5. Boruette T, Anton R. Clinical Rewiev of inhalants (2001) Am J Addict; 10: 79-94.
6. Brown ES, Jeffress J, Liggin JD, Garza M, Beard L (2005) Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole. J Clin Psychiatry; 66: 756-760. (Pubitemid 40942423)
7. Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, Molinoff PB (2002) Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther; 302: 381-389. (Pubitemid 34680462)
8. Childress AR, O'Brien CP (2000) Dopamine receptor partial agonists could address the duality of cocaine craving. Trends Pharmacol Sci; 21: 6-9.
9. Ercan ES, Amado S, Somer O Cikoglu S (2001) Dikkat eksikliǧi hiperaktivite bozukluǧu ve yikici davranim bozukluklari için bir test bataryasi geliştirme çabasi. Çocuk ve Gençlik Ruh Saǧliǧi Dergisi; 8: 132-144.
10. Evren C, Barut T, Saatcioglu O, Cakmak D (2006) Axis I psychiatric comorbidity among adult inhalant dependents seeking treatment. J Psychoact Drugs; 38: 57-64.
11. Findling RL (2008) Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents. J Clin Psychiatry; 69 Suppl 4: 9-14.
12. Findling RL, Kauffman R, Sallee FR, Salazar DE, Sahasrabudhe V, Kollia G, Kornhauser DM, Vachharajani NN, Assuncao-Talbott S, Mallikaarjun S, Iwamoto T, McQuade RD, Boulton DW, Blumer J (2009) An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder. J Child Adolesc Psychopharmacol; 19: 431-439.
13. Grant BF, Stinson, FS, Dawson DA, Chou SP, Dufour MC, Compton W (2004) Prevalence of co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry; 61: 807-816.
14. Greenaway M, Elbe D (2009) Focus on Aripiprazole: A Review of its use in Child and Adolescent Psychiatry. J Can Acad Child Adolesc Psychiatry; 18: 250-60.
15. Hart CL (2005) Increasing treatment options for cannabis dependence: Areview of potential pharmacotherapies. Drug Alcohol Depend; 80: 147-159.
16. Hansen WB, Rose LA (1995) Recretional use of inhalant rugs by adolescents: a challenge for family physicians. Fam Med; 27: 383-387.
17. Hernandez-Avila CA, Ortega-Soto HA, Jasso A, Hasfura-Buenaga CA, Kranzler HR (1998) Treatment of inhalant-induced psychotic disorder with carbamazepine versus haloperidol. Psychiatr Serv; 49: 812-815.
18. Howard MO, Jenson JM (1999) Inhalant use among antisocial youth: prevalence and correlates. Addict Behav; 24: 59-74.
19. Kaya B, Özcan ME (1999) Uçucu Baǧimliliǧi ve Kötüye Kullanimi: Epidemiyoloji, Risk Gruplari ve Önleme Programlarinin Gerekliliǧi. Klinik psikiyatri; 2: 189-196.
20. Kurtzman TL, Kimberlyn BA, Otsuka MD, Wahl RA (2001) Inhalant abuse by adolescents. Journal Adolesc Health; 28: 170-180.
21. Li Z, Ichikawa J, Dai J,Meltzer HY (2004) Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. Eur J Pharmacol; 493: 75-83. (Pubitemid 38746934)
22. Lile JA, Stoops WW, Vansickel AR, Glaser PE, Hays LR, Rush CR (2005) Aripiprazole attenuates the discriminative-stimulus effects of d-amphetamine in humans. Neuropsychopharmacol; 30: 2103-2114.
23. Mackesy-Amiti ME, Fendrich M (1999) Inhalant use and delinquent behavior among adolescents: a comparison of inhalant users and other drug users. Addiction; 94: 555-564.
24. Maruff P, Burns CB, Tyler P, Currie BJ, Currie J (1998) Neurological and cognitive abnormalities associated with chronic petrol sniffing. Brain; 121: 1903-1917.
25. Mcgarvey EL, Canterbury RJ, Waite D (1996) Delinquency and family problems in incarcerated adolescents with and without a history of inhalant use. Addict Behav; 21: 537-542.
26. Meadows R, Verghese A (1996) Medical complications of glue sniffing. South Med J; 89: 455-462.
27. Ogel K, Tamar D, Evren E, Cakmak D (2000) Ucucu madde kullaniminin yayginligi: Cok merkezli bir arastirmanin verilerinin degerlendirilmesi. Anadolu PsIkiyatri Dergisi; 1: 220-224.
28. Ogel K, Tamar D, Evren E, Cakmak D (2001) Lise gencleri arasinda sigara, alkol ve madde kullanim yayginligi. Turk Psikiyatri Derg; 12: 47-52.
29. Shane P, Jasiukaitis P & Green RS (2003). Treatment outcomes among adolescents with substance abuse problems: The relationship between comorbidities and post-treatment substance involvement. Eval Program Plann; 26. 393-402. (Pubitemid 37160193)
30. Smelson D, Roy A, Roy M (1997) Risperidone diminishes cueelicited craving in withdrawn cocaine dependent patients. Can J Psychiatry; 42: 984. (Pubitemid 28041859)
31. Warsi M, Sattar SP, Bhatia SC, Petty F (2005) Aripiprazole reduces alcohol use. Can J Psychiatry; 50: 244.
32. Wee S, Wang Z, Woolverton Z, Pulvirenti L, Koob GF (2007) Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration. Neuropsychopharmacol; 32: 2238-2247.
33. Wu L, Howard MO (2007) Psychiatric disorders in inhalant users: results from The National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcoh Dep; 88: 146-155.
34. Yaşan A, Gürgen F (2004) Güneydoǧu anadolu bölgesinde ergenlerde uçucu madde kullanim özellikleri. Baǧimlilik Dergisi; 5: 77-83.